ArticleJournal of veterinary research2026
Chloramine T in pikeperch (
Article in Journal of veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chloramine T (CLT) is utilised in aquaculture for its disinfectant and antiseptic properties, yet its physiological effects on fish health remain underexplored, particularly in emerging species like pikeperch ( Material and Methods: A total of 270 fish were assigned to a control group (C), a single-bath group (10 mg L Results: Growth parameters and condition factor (ratio of body weight to the cube of body length) remained stable across all groups, and no mortality was observed. Liver enzyme activities showed no significant alterations; however, inflammatory changes were noted in the liver in the CLT3 group. Serum lysozyme activity increased after the initial exposure, indicating an acute immune response. In contrast, repeated exposure reduced respiratory burst and phagocyte killing activity, suggesting immunosuppression; however, CLT3-group T and B lymphocytes proliferated more as a reaction to inflammation. Conclusion: While CLT at 10 mg L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.